CBZ enhances use-dependent inhibition of V810M and WT channels. (a)
Voltage-dependent activation of WT (left; DMSO: solid black squares,
n = 15; CBZ: open black squares,
n = 12) and V810M (right; DMSO: solid red circles,
n = 15; CBZ: open red circles,
n = 13) channels show no shift in activation following
a 30-min preincubation period with 30 µM CBZ as compared to 0.1% DMSO
vehicle. Conductance curves were normalized to the maximum conductance
value and fit to a Boltzmann equation. (b) Representative traces of
use-dependent inhibition of WT channels following a 30-min preincubation
period with either 0.1% DMSO vehicle (left) or 30 µM CBZ (right). (c)
Representative traces of use-dependent inhibition of V810M channels
following a 30-min preincubation period with either 0.1% DMSO vehicle
(left) or 30 µM CBZ (right). (d) Use-dependent inhibition curves of WT
(DMSO: solid black squares, n = 15; CBZ: open black
squares, n = 12) and V810M (DMSO: solid red circles,
n = 14; CBZ: open red circles,
n = 12) channels showing a significant difference
between DMSO and CBZ conditions for both channels
(p < 0.05). Use-dependent inhibition was recorded at
20 Hz and defined as the ratio of peak current of the 30th pulse
normalized to peak current of the first pulse. CBZ: carbamazepine; DMSO:
dimethyl sulfoxide.